In the multicenter PIVENS ( PI oglitazone versus V itamin E versus placebo for the treatment of N onalcoholic S teatohepatitis) trial, 247 subjects with MASH but not diabetes mellitus were randomized to receive 30 mg/day of pioglitazone (an insulin-sensitizing drug), 800 IU/day (536 mg/day) of RRR --tocopherol, or a placebo for 96 weeks (97)
The points below reflect reported experiences with microdosing GLP-1 medications rather than outcomes confirmed by clinical research
Children with this condition may develop dark-colored spots on the mouth, lips, eyes, nose, hands, and feet
According to the company, HSA and FSA payments are accepted
Normally no, apart from an achy muscle at the injection site, which normally does not last for more than an hour or so